PGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Progressive Corp (PGR) is not an immediate buy for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown strong financial performance in May 2026 and has positive sentiment from Congress trading data, the lack of strong technical buy signals, mixed analyst ratings, and a short-term bearish stock trend suggest waiting for a better entry point.
The MACD is positive at 0.819, indicating bullish momentum, but it is contracting. RSI at 65.876 is in the neutral zone, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision. Key support and resistance levels are at S1: 198.506 and R1: 207.016. The stock is trading near its pivot point of 202.761.
Strong financial performance in May 2026, with a 36% increase in net income and 6% growth in net premiums written.
Positive sentiment from Congress trading data, with 2 purchase transactions and only 1 sale transaction in the last 90 days.
Analysts highlight Progressive's potential as a beneficiary in the emerging AI economy.
Analysts have mixed ratings, with some lowering price targets due to deteriorating margins and moderating growth.
Short-term stock trend indicates a potential decline of -1.04% in the next day, -3.49% in the next week, and -5.86% in the next month.
No significant hedge fund or insider trading activity to indicate strong institutional confidence.
Progressive reported strong May 2026 results, with net premiums written increasing by 6% year-over-year to $7.03 billion and net income rising by 36% to $1.445 billion or $2.47 per share. However, analysts note potential margin deterioration due to rate decreases and moderating growth.
Analysts have mixed views. BofA maintains a Buy rating with a price target of $313, citing Progressive's unique positioning in the AI economy. However, Wells Fargo and Keefe Bruyette maintain neutral ratings, citing deteriorating margins and limited growth catalysts. Recent price target changes range from $208 to $313.
